A Phase I Clinical Study of VSA012 in Healthy Volunteers

NCT06766929 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: VSA012
DRUG: Placebo

Sponsor

Bisirna Therapeutics (Suzhou) Co., Ltd.